Transcatheter aortic valve implantation for pure aortic insufficiency in a patient following David-type aortic valve-sparing root replacement after aortic dissection-A successful off-label procedure.
Didem Melis OztasEmrah OzdemirRobert BauernschmittMurat UğurlucanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
Transcatheter aortic valve implantation (TAVI) has traditionally been indicated for the treatment of aortic stenosis. However, in this case report, we describe a successful TAVI procedure in a 46-year-old male patient who had previously undergone David aortic valve-sparing aortic root replacement for type 1 aortic dissection. The patient presented with aortic valve insufficiency 4 years after the initial surgery and was subsequently treated with a 34 mm Medtronic CoreValve Evolut R prosthesis via TAVI. This case highlights the feasibility of TAVI as a viable treatment option for postoperative aortic valve insufficiency in patients with prior ascending aortic or aortic arch surgery.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- aortic dissection
- aortic valve replacement
- case report
- transcatheter aortic valve replacement
- minimally invasive
- robot assisted
- patients undergoing
- heart failure
- coronary artery disease
- left ventricular
- acute coronary syndrome
- ejection fraction
- replacement therapy
- atrial fibrillation
- coronary artery